Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02342626 · ClinicalTrials.gov registry record · NA
Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 140
- Enrollment target
NCT02342626 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 140 participants.
The verdict
NCT02342626, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
Study Summary
The overall goal of this project is to test an interactive, multi-media decision aid in the form of an electronic clinical decision dashboard designed to improve the quality of clinical decision making for initial treatment of patients with newly diagnosed, low or intermediate risk prostate cancer.
Interventions
- BEHAVIORAL Dashboard
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02342626
The ClinicalTrials.gov registry entry for NCT02342626 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dashboard is the first listed.
NCT02342626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02342626 about?
NCT02342626 is a clinical study titled "Devel. and Eval. of an Active Surveillance Decision Aid for Men With Low or Intermediate Grade Prostate Cancer". The overall goal of this project is to test an interactive, multi-media decision aid in the form of an electronic clinical decision dashboard designed to improve the quality of clinical decision making for initial treatment of patients with newly diagnosed, low or intermediate risk prostate cancer.
What is the current status of trial NCT02342626?
This trial is currently completed. It is a NA study. The enrollment target is 140 participants. The study started on 2015-01. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02342626?
The interventions under investigation include: Dashboard (BEHAVIORAL).
Who is sponsoring clinical trial NCT02342626?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.